Your browser doesn't support javascript.
loading
The role of the NADPH oxidase NOX2 in prion pathogenesis.
Sorce, Silvia; Nuvolone, Mario; Keller, Annika; Falsig, Jeppe; Varol, Ahmet; Schwarz, Petra; Bieri, Monika; Budka, Herbert; Aguzzi, Adriano.
Afiliación
  • Sorce S; Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
  • Nuvolone M; Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
  • Keller A; Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
  • Falsig J; Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
  • Varol A; Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
  • Schwarz P; Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
  • Bieri M; Institute of Surgical Pathology, University Hospital of Zurich, Zurich, Switzerland.
  • Budka H; Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
  • Aguzzi A; Institute of Neuropathology, University Hospital of Zurich, Zurich, Switzerland.
PLoS Pathog ; 10(12): e1004531, 2014 Dec.
Article en En | MEDLINE | ID: mdl-25502554
ABSTRACT
Prion infections cause neurodegeneration, which often goes along with oxidative stress. However, the cellular source of reactive oxygen species (ROS) and their pathogenetic significance are unclear. Here we analyzed the contribution of NOX2, a prominent NADPH oxidase, to prion diseases. We found that NOX2 is markedly upregulated in microglia within affected brain regions of patients with Creutzfeldt-Jakob disease (CJD). Similarly, NOX2 expression was upregulated in prion-inoculated mouse brains and in murine cerebellar organotypic cultured slices (COCS). We then removed microglia from COCS using a ganciclovir-dependent lineage ablation strategy. NOX2 became undetectable in ganciclovir-treated COCS, confirming its microglial origin. Upon challenge with prions, NOX2-deficient mice showed delayed onset of motor deficits and a modest, but significant prolongation of survival. Dihydroethidium assays demonstrated a conspicuous ROS burst at the terminal stage of disease in wild-type mice, but not in NOX2-ablated mice. Interestingly, the improved motor performance in NOX2 deficient mice was already measurable at earlier stages of the disease, between 13 and 16 weeks post-inoculation. We conclude that NOX2 is a major source of ROS in prion diseases and can affect prion pathogenesis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Priones / Glicoproteínas de Membrana / Síndrome de Creutzfeldt-Jakob / Enfermedades por Prión / NADPH Oxidasas Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2014 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Priones / Glicoproteínas de Membrana / Síndrome de Creutzfeldt-Jakob / Enfermedades por Prión / NADPH Oxidasas Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2014 Tipo del documento: Article País de afiliación: Suiza